ALK Inhibitors for Lung Cancer: Generational Evolution and Impact on Clinical Practice
Before the advent of targeted therapy, ALK-positive advanced non-small cell lung cancer (NSCLC) typically progressed…
News
From First- to Third-Generation EGFR-targeted Drugs: How Can Patients Understand Differences in Efficacy and Adverse Effects?
Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small…
What Is Qipani Olaparib Used For? China Approves First Domestic Olaparib Generic, Marking a New Milestone in PARP Inhibitor Access
In May 2023, China’s National Medical Products Administration (NMPA) approved the first domestically developed generic…
Top 5 Global Rare Disease Companies: An In-Depth Analysis of Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex
In recent years, rare disease treatment has rapidly risen from a niche medical issue to…
What Class of Drug Is Penpulimab? How This Fc-Engineered PD-1 Monoclonal Antibody Restores Anti-Tumor Immunity?
In recent years, immune checkpoint inhibitors have revolutionized the field of anti-tumor treatment, among which…
Abbisko’s Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor: China’s First Class-1 CSF-1R Inhibitor Approved for TGCT
In the field of tenosynovial giant cell tumor (TGCT), a rare but persistent disease that…
What Is Ponatinib Used For? Targeting T315I-Mutant CML and Ph+ ALL
In the treatment of leukemia, not all patients respond equally to standard therapies. Drug resistance…
Adebrelimab Approval in China: The First Domestic PD-L1 Antibody for Small Cell Lung Cancer
Adebrelimab approval in China marks a significant milestone in the country’s oncology landscape. In 2023,…
Darzalex Faspro or Darzalex: What’s the Difference Between Two Forms of Daratumumab
Multiple myeloma is a chronic and often relapsing hematologic malignancy that requires long-term, repeated treatment.…
Secukinumab Injection Uses Explained: Why IL-17A Inhibition Is Reshaping Treatment for Psoriasis and Inflammatory Arthritis
Biologic therapies have fundamentally changed how chronic inflammatory diseases are treated, shifting the focus from…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights